Pacira Biosciences Joins PROBE Consortium to Advance Osteoarthritis Research
I'm PortAI, I can summarize articles.
Pacira Biosciences Inc. has joined the PROBE Consortium, a public-private partnership funded by the European Innovative Health Initiative, to advance osteoarthritis research. The consortium aims to improve OA diagnosis and treatment using data from over 70 million individuals. Pacira will contribute data from its ASCEND study to support AI-driven disease progression prediction and development of new trial endpoints. This initiative involves 38 partners from various sectors to enhance patient care.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments